Serum Albumin Kinetics in Major Ovarian, Gastrointestinal, and Cervico Facial Cancer Surgery.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 03 2022
Historique:
received: 24 01 2022
revised: 28 02 2022
accepted: 10 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 19 4 2022
Statut: epublish

Résumé

Hypoalbuminemia in major cancer surgery can lead to postoperative short and long-term complications. Our study was designed to detect albumin variations in three major cancer surgeries: ovarian debulking (DBK), major abdominal gastrointestinal surgery (ABD), and major cervico-facial, or ear, nose and throat cancer surgery (ENT). Single-center prospective study inclusion criteria were non-emergency procedures scheduled to last at least five hours. We performed hourly perioperative monitoring of the patients’ albuminemia and hemoglobinemia. Electronic charts were followed for at least five years for survival analysis. Sixty-three patients were analyzed: 30 in the DBK group, 13 in the ABD group, and 20 in the ENT group. There was a significant difference in albumin decrease between the ENT group and the two others (−19% at six hours in the ENT group versus -49% in the debulking group and −31% in the ABD group (p < 0.05). There was no significant difference between the DBK and ABD groups. The decrease in hemoglobin was not significantly different between the groups, and no significant difference was observed in long-term survival. DBK and ABD surgery yielded significant hypoalbuminemia. Therefore, the extent of decrease in serum albumin is probably not the only etiology of the specific postoperative complications of these major surgeries. No significant difference was noticed in five-year mortality, and no correlation was found in relation to the degree of intraoperative albumin kinetics.

Identifiants

pubmed: 35329082
pii: ijerph19063394
doi: 10.3390/ijerph19063394
pmc: PMC8955132
pii:
doi:

Substances chimiques

Serum Albumin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Epidemiol. 1999 Feb 15;149(4):372-8
pubmed: 10025481
Br J Anaesth. 2000 Oct;85(4):599-610
pubmed: 11064620
BMC Cancer. 2021 Aug 26;21(1):961
pubmed: 34445989
World J Gastroenterol. 2017 Jul 21;23(27):4978-4985
pubmed: 28785152
BMJ Open Gastroenterol. 2015 Aug 04;2(1):e000047
pubmed: 26462287
PLoS One. 2015 Aug 27;10(8):e0136371
pubmed: 26313170
BMC Surg. 2020 Jul 14;20(1):155
pubmed: 32664910
J Clin Anesth. 2011 Feb;23(1):42-6
pubmed: 21296246
Acta Ortop Bras. 2020 Jul-Aug;28(4):168-171
pubmed: 32788857
J Invest Surg. 2022 Feb;35(2):426-431
pubmed: 33021127
Acta Anaesthesiol Scand. 2002 Feb;46(2):166-72
pubmed: 11942864
Crit Care. 2016 Apr 26;20(1):113
pubmed: 27117323
Anesth Analg. 2010 Apr 1;110(4):1242; author reply 1243
pubmed: 20357164
Scand J Surg. 2021 Mar;110(1):29-36
pubmed: 31769347
BMC Urol. 2018 Dec 6;18(1):111
pubmed: 30522461
Cancer Manag Res. 2019 Aug 14;11:7697-7705
pubmed: 31616185
Acta Anaesthesiol Scand. 1998 Jan;42(1):39-46
pubmed: 9527742
Gastroenterol Res Pract. 2016;2016:8743187
pubmed: 26880899
Arch Surg. 2008 Sep;143(9):907-11; discussion 911-2
pubmed: 18794430
Crit Care Med. 2015 Dec;43(12):2552-61
pubmed: 26308436
ANZ J Surg. 2019 Jul;89(7-8):E297-E301
pubmed: 31297940
J Gastrointest Surg. 2007 Oct;11(10):1355-60
pubmed: 17682826
BMJ Open. 2017 Apr 8;7(4):e013966
pubmed: 28391235

Auteurs

Cyrus Motamed (C)

Department of Anesthesia, Institut de Cancerologie Gustave Roussy, 94080 Paris, France.

Lucie Mariani (L)

Department of Anesthesia and Intensive Care, APHP Hopital Pitié Salpétrière, 75013 Paris, France.

Stéphanie Suria (S)

Department of Anesthesia, Institut de Cancerologie Gustave Roussy, 94080 Paris, France.

Gregoire Weil (G)

Anesthesia Department, Centre Hospitalier d'Orleans, 45100 Orléans, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH